In their observation, heteronemin inhibited both trypsin and chymotrypsin-like proteasome activity at an IC50 value of 0.4 μM thereby inhibiting NF-κB activation and proving to be detrimental to cancer cells via apoptosis [52]. The gene discussed is NFKB1; the disease is cancer.